[Corrigendum] The effect of NFATc1 on vascular generation and the possible underlying mechanism in epithelial ovarian carcinoma
Affiliations: Department of Physical Examination, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China, Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China, Department of PICU, Children's Hospital of Chongqing Medical University, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing 400016, P.R. China
- Published online on: October 12, 2020 https://doi.org/10.3892/ijo.2020.5131
- Pages: 1381-1381
Copyright : © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].
This article is mentioned in:
Int J Oncol 48: [Related article:] 1457-1466, 2016; DOI: 10.3892/ijo.2016.3355
Following the publication of the above article, the authors have realized that some incorrect data were included in Fig. 6 in their paper; essentially, the CXCR2 protein bands that were included in the figure were irrelevant, and data for interleukin-8 (IL-8) should have been selected and included in the figure instead.
The expression of NFATc1 (91 bp)/IL-8 (11 bp)/FGF-2 (15.8 bp)/PDGF BB (24.4 bp) proteins in control groups and siRNA group was assessed by western blot analysis. The final protein size of β-actin (43 bp) was the same. The expression of these proteins was higher in the control group compared to the siRNA group, the expression level of IL-8/FGF-2/PDGF BB decreased along with the expression of NFATc1, suggesting that there was transcriptional activation of the expression of these proteins in ovarian cancer cells, and NFATc1 siRNA inhibited the protein expression of IL-8/FGF-2/PDGF BB.
The corrected version of Fig. 6 is shown opposite, now featuring the IL-8 data. The authors confirm that these errors did not significantly influence either the results or the conclusions in their paper. The authors are grateful to the Editor of International Journal of Oncology for allowing them the opportunity to publish this corrigendum, and apologize to the readership for any inconvenience caused.